Ireland

The Republic of Ireland’s record in life sciences is impressive. Decades of investment, education and training have been major winners for the country’s successful economy. But its success is drawing unwanted attention from the US. Trump wants “to have that.”

Generics Bulletin reviews global regulatory developments across the world.

The US president's most recent comments suggest tariffs on pharma are imminent and Ireland has the most to lose.

Generics Bulletin reviews global regulatory developments across the globe.

Medicines for Ireland had its demands for the off-patent sector heard by some political parties, which are pledging to improve access to generic and biosimilar drugs ahead of the election.

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Leadership changes at Norgine, IPHA and Orifarm feature in this week's round-up of European consumer health people news.

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.

An end to litigation filed by institutional investors, insurance companies and pension funds comes four CEOs after Perrigo's chief exec during Mylan's tender in 2015, Joseph Papa, resigned to lead another firm in 2016. Plaintiff attorneys are asking for up to 20% of settlement in fees.

Standard templates for clinical trial agreements are expected to help do away with the costs and delays arising from the use of different versions in Ireland.